The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.
Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eight closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.
Five of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in StemTherapy, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.
We are very pleased to announce the arrival of Filipe Pereira to the Division of Molecular Medicine and Gene Therapy, where he will build a lab that will focus on Cell Reprogramming and Hematopoiesis. Filipe was recruited to Lund University as a Wallenberg Fellow in Molecular Medicine within the field of regeneration, replacement, and repair in the hematopoietic system at the Lund Stem Cell Center. He joins us from the University of Coimbra, Portugal, where he currently holds an Assistant Professor position.
Filipe completed his undergraduate training in biology at the University of Porto, Portugal, before undertaking a PhD in epigenetics and cellular reprogramming at the Imperial College of London, UK. He then spent time as a postdoctoral fellow at the MRC Clinical Sciences Centre, Imperial, College School of Medicine, London, UK before continuing his training at the Department of Developmental and Regenerative Biology at Icahn School of Medicine at Mount Sinai, New York, USA, to extend his studies in cellular reprogramming and hematopoiesis.
Welcome to our Division and to Lund, Filipe!
On September 14, Roksana Moraghebi, Division of Molecular Medicine and Gene Therapy, will defend her thesis entitled "The effects of genetic and epigenetic variation on human iPSC differentiation".
Time and venue
Thursday September 14 at 9 am; Belfrage Lecture Hall, BMC D15
Professor Hanna Mikkola, University of California Los Angeles, USA
Associate Professor Niels-Bjarne Woods
Professor Jonas Larsson
In connection with Roksana’s thesis defence, Professor Hanna Mikkola from UCLA will give a talk entitled "Hematopoietic stem cells in the making" on Wednesday September 13th at 11:00 in the Segerfalk Lecture Hall, BMC A10. Welcome!
Congratulations to Emma Rörby, a previous PhD student in Stefan Karlsson's group, and coworkers, whose work "The stem cell regulator PEDF is dispensable for maintenance and function of hematopoietic stem cells" has recently been published in Scientific Reports.
In this study, the authors show that the stem cell regulator Pigment epithelium-derived factor (PEDF) does not regulate hematopoietic stem cells despite its critical role for self-renewal of various other tissue types.
Congratulations to all authors!